What is LOPJLB’s current signal on PCRX?

LOPJLB’s latest quantitative signal on Pacira BioSciences, Inc. (PCRX) is BUY in a BULL regime. Signals are updated daily.

What market regime is PCRX in?

Pacira BioSciences, Inc. (PCRX) is currently classified in the BULL HMM market regime on LOPJLB.

Where is Pacira BioSciences, Inc. based / listed?

Pacira BioSciences, Inc. is based in US, listed on NASDAQ.

Pacira BioSciences, Inc. (PCRX)

COMPARE

Healthcare · Drug Manufacturers - Specialty & Generic · NASDAQ · US

$36.31-0.22%Close

BUYBULL · day 1

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $1.4B
Beta: 0.27
P/E (TTM): 70.32

Short % float: 21.44%
Days to cover: 15.1
SI change: +6.8%

1W: +44.03%
1M: +44.32%

vs SPY 1W: +42.87%
vs SPY 1M: +41.32%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health. Its offerings include EXPAREL, an injectable liposomal bupivacaine…

Employees: 827
Headquarters: US
Founded: 2011
Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares out: 39.3M
Float: 95.8%

pacira.com ↗

Key executives

Frank D. Lee — Chief Executive Officer & Director

Lauren Bullaro Riker — Principal Accounting Officer & Senior Vice President of Finance

Brendan Teehan — Chief Commercial Officer

SEC filings

EDGAR · CIK 13968140 · PCRX

Analyst consensus

Hold

Bullish1130.6%

Neutral2261.1%

Bearish38.3%

L $25.00Avg $31.67H $36.50

Target$31.67-12.78%

Last$36.31

Key stats

Industry peers

Prediction markets

Company news